ZEB2 and acute myeloid leukemia: The results (as shown in Figure 7) indicated that high expression of lncRNA CRNDE and TUG1 was associated with a reduced OS in AML patients, and high expression of lncRNA ZEB2-AS1 was associated with a decreased DFS in AML patients, with statistically significant differences.